Effect of Aragwadhadi Varti (Vaginal Suppository) on Abnormal Vaginal Discharge

A Clinical Study of Aragwadhadi Varti in Abnormal Vaginal Discharge

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/045114

Enrollment

Registered

2022-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Married women Age group between 18 to menopause The subjects who have the complaint of Vaginal Discharge along with any one of the complaint of pain or Vulval itching A. Vaginal discharge B. Vulval Itching C. Pain

Exclusion criteria

Exclusion criteria: Unmarried & married below the age of 18 year Post menopausal women Pregnant women Known malignancy

Design outcomes

Primary

Measure	Time frame
Improvement in cardinal and associated clinical features related to Abnormal Vaginal Discharge , pain , itching , vaginal ph Timepoint: 60 Days	—

Secondary

Measure	Time frame
Improvement in associated clinical features related to Abnormal Vaginal Discharge like weakness, burning micturation , local Tenderness Timepoint: 60 Days	—

Countries

India

Contacts

Public ContactDr A Neelima

University Post Graduate of Ayurved Studies and Research, Jodhpur, Rajasthan

aspneelima@gmail.com9610350131

Outcome results